Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abida Khan

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Molecular Diversity|January 14, 2026
Exploring structural diversity and dynamic stability of small-molecule PRMT5 inhibitors through machine learning-based QSAR and molecular modellingAbida Khan
Acta Poloniae Pharmaceutica|November 4, 2014
Antifungal and cytotoxic activities of Nannorrhops ritchiana roots extractRehana Rashid, Farah Mukhtar, Abida Khan
Molecular Diversity|July 29, 2025
Identifying dormancy-associated enzymes in Mycobacterium tuberculosis through a computational pipeline integrating flux balance analysis and metabolic modelingMohd Imran, Ahmed S Alshrari, Abida Khan
Biogerontology|March 5, 2025
Aging, vascular dysfunction, and the blood-brain barrier: unveiling the pathophysiology of stroke in older adultsSaleh I Alaqel, Mohd Imran, Abida Khan, et al.
Drug Development Research|March 17, 2020
Synthesis of novel N-substitutedphenyl-6-oxo-3-phenylpyridazine derivatives as cyclooxygenase-2 inhibitorsAbida Khan, Anupama Diwan, Hamdy K Thabet, et al.
Frontiers in Cellular and Infection Microbiology|November 27, 2025
IFN-γ-Driven macrophage responses in the immunity to <i>Mycobacterium tuberculosis</i> and <i>Mycobacterium leprae</i>Mohd Imran, Ahmed S Alshrari, Abida Khan, et al.
Molecular Diversity|April 10, 2026
Predictive bioactivity modeling and structural binding analysis for the identification of potential SMYD3 modulatorsAbdullah R Alzahrani, Zia Ur Rehman, Talha Jawaid, et al.
Molecules (Basel, Switzerland)|April 30, 2020
Discovery of Novel Pyridazine-Based Cyclooxygenase-2 Inhibitors with a Promising Gastric Safety ProfileAbida Khan, Anupama Diwan, Hamdy Kh Thabet, et al.
Drug Discovery Today|May 9, 2025
Genetic-epigenetic targets for PCOS-associated diabesityArun K Sharma, Monalisa Mukherjee, Md Sayeed Akhtar, et al.
Drug Discovery Today|May 14, 2026
Microbial dysbiosis in metabolic disorders: linking epigenomic regulation and pathological mechanismsArun K Sharma, Md Sayeed Akhtar, Khalid Orayj, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Molecular Diversity|January 14, 2026
Exploring structural diversity and dynamic stability of small-molecule PRMT5 inhibitors through machine learning-based QSAR and molecular modellingAbida Khan
Acta Poloniae Pharmaceutica|November 4, 2014
Antifungal and cytotoxic activities of Nannorrhops ritchiana roots extractRehana Rashid, Farah Mukhtar, Abida Khan
Molecular Diversity|July 29, 2025
Identifying dormancy-associated enzymes in Mycobacterium tuberculosis through a computational pipeline integrating flux balance analysis and metabolic modelingMohd Imran, Ahmed S Alshrari, Abida Khan
Biogerontology|March 5, 2025
Aging, vascular dysfunction, and the blood-brain barrier: unveiling the pathophysiology of stroke in older adultsSaleh I Alaqel, Mohd Imran, Abida Khan, et al.
Drug Development Research|March 17, 2020
Synthesis of novel N-substitutedphenyl-6-oxo-3-phenylpyridazine derivatives as cyclooxygenase-2 inhibitorsAbida Khan, Anupama Diwan, Hamdy K Thabet, et al.
Frontiers in Cellular and Infection Microbiology|November 27, 2025
IFN-γ-Driven macrophage responses in the immunity to <i>Mycobacterium tuberculosis</i> and <i>Mycobacterium leprae</i>Mohd Imran, Ahmed S Alshrari, Abida Khan, et al.
Molecular Diversity|April 10, 2026
Predictive bioactivity modeling and structural binding analysis for the identification of potential SMYD3 modulatorsAbdullah R Alzahrani, Zia Ur Rehman, Talha Jawaid, et al.
Molecules (Basel, Switzerland)|April 30, 2020
Discovery of Novel Pyridazine-Based Cyclooxygenase-2 Inhibitors with a Promising Gastric Safety ProfileAbida Khan, Anupama Diwan, Hamdy Kh Thabet, et al.
Drug Discovery Today|May 9, 2025
Genetic-epigenetic targets for PCOS-associated diabesityArun K Sharma, Monalisa Mukherjee, Md Sayeed Akhtar, et al.
Drug Discovery Today|May 14, 2026
Microbial dysbiosis in metabolic disorders: linking epigenomic regulation and pathological mechanismsArun K Sharma, Md Sayeed Akhtar, Khalid Orayj, et al.
Pageof 6